Genomics and proteomics approaches to the study of cancer-stroma interactions

BMC Medical Genomics

Volumn 3, Issue , 2010, Pages

  Cury, P M ^a   de Carvalho, M B ^h   Dias Neto, E ^d,i   Figueiredo, D L A ^d   Fukuyama, E E ^e   Gois Filho J F ^e   Leopoldino, A M ^d   Mamede, R C M ^d   Michaluart Junior, P ^d   Moyses, R A ^d   Nobrega F G ^b   Nobrega M P ^b   Nunes, F D ^d   Ojopi, E P B ^d   Serafini, L N ^d   Severino, P ^g   Silva, A M A ^h   Silva, W A ^d   Silveira, N J F ^j   Souza, S C O M ^d   Tajara, E H ^a   Wunsch Filho V ^d   Amar, A ^h   Bandeira, C M ^b   Braconi, M A ^b   Brandao L G ^d   Brandao R M ^d   Canto, A L ^b   Cerione, M ^e   Cicco, R ^e   Chagas, M J ^b   Chedid, H ^h   Costa, A ^d   Cunha, B R ^a   Curioni, O A ^h   Fortes, C S ^d   Franzi, S A ^h   Frizzera, A P Z ^a   Gazito, D ^h   Guimaraes P E M ^d   Kaneto, C M ^d   Lopez R V M ^d   Macarenco, R ^b   Magalhaes M R ^h   Meneses, C ^b   Mercante, A M C ^h   Pinheiro, D G ^d   Polachini, G M ^a   Rapoport, A ^h   Rodini, C O ^d   Rodrigues Lisoni, F C ^a   Rodrigues, R V ^a   Rossi, L ^h   Santos, A R D ^d   Santos, M ^h   Settani, F ^e   Silva, F A M ^d   Silva, I T ^d   Souza, T B ^h   Stabenow, E ^d   Takamori, J T ^h   Valentim, P J ^e   Vidotto, A ^a   Xavier, F C A ^d   Yamagushi, F ^e   Cominato, M L ^e   Correa, P M S ^b   Mendes, G S ^e   Paiva, R ^e   Ramos, O ^d   Silva, C ^d   Silva, M J ^e   Tarla M V C ^d   more..

^a FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c School of Medicine   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e Instituto do Cancer Dr Arnaldo   (Brazil)

^f Heliápolis Hospital   (Brazil)

^g Instituto Israelita de Ensino e Pesquisa Albert Einstein   (Brazil)

^h HOSPITAL HELIÓPOLIS   (Brazil)

ⁱ A C CAMARGO CANCER CENTER   (Brazil)

^j FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA ENOLASE; CALRETICULIN; FRUCTOSE BISPHOSPHATE ALDOLASE; FRUCTOSE BISPHOSPHATE ALDOLASE ISOENZYME; GENE PRODUCT; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GUANINE NUCLEOTIDE BINDING PROTEIN BETA POLYPEPTIDE 2 LIKE 1; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C2; RETINOBLASTOMA BINDING PROTEIN 1; RING FINGER PROTEIN; RING FINGER PROTEIN 10; SEQUESTOSOME 1; TUBULIN; TUBULIN BETA; UBIQUITIN SPECIFIC PEPTIDASE 9 X LINKED; UNCLASSIFIED DRUG; VIMENTIN; KERATIN; LIPOCORTIN 5; PROTEOME;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; FIBROBLAST CULTURE; GENE EXPRESSION; GROWTH CURVE; HEAD AND NECK TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUTH CANCER; PARACRINE SIGNALING; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAPID SUBTRACTION HYBRIDIZATION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; STROMA CELL; SUBTRACTIVE HYBRIDIZATION; TONGUE CARCINOMA; TWO DIMENSIONAL GEL ELECTROPHORESIS; CELL STRAIN HEPG2; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; MASS SPECTROMETRY; METABOLISM; MOUTH TUMOR; NUCLEIC ACID HYBRIDIZATION;

ANNEXIN A5; APOPTOSIS; CELL PROLIFERATION; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; HEP G2 CELLS; HUMANS; KERATINS; MOUTH NEOPLASMS; NUCLEIC ACID HYBRIDIZATION; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STROMAL CELLS; VIMENTIN;

EID: 77952828385     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-3-14     Document Type: Article

References (99)

1. FN Kumar V A Abbas, Robbins & Cotran: Pathologic Basis of Disease Philadelphia: Saunders 2004
2. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. HF Dvorak, N Engl J Med 1986 315 26 1650 1659 3537791
3. Know thy neighbor: stromal cells can contribute oncogenic signals. TD Tlsty PW Hein, Curr Opin Genet Dev 2001 11 1 54 59 10.1016/S0959-437X(00)00156-8 11163151
4. Tumor microenvironment: the role of the tumor stroma in cancer. H Li X Fan J Houghton, J Cell Biochem 2007 101 4 805 815 10.1002/jcb.21159 17226777
5. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues. H Zhao CF Ramos JD Brooks DM Peehl, J Cell Physiol 2007 210 1 111 121 10.1002/jcp.20828 17044071
6. Stromal gene expression predicts clinical outcome in breast cancer. G Finak N Bertos F Pepin S Sadekova M Souleimanova H Zhao H Chen G Omeroglu S Meterissian A Omeroglu,, et al. Nat Med 2008 14 5 518 527 10.1038/nm1764 18438415 (Pubitemid 351655218)
7. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. M Ao OE Franco D Park D Raman K Williams SW Hayward, Cancer Res 2007 67 9 4244 4253 10.1158/0008-5472.CAN-06-3946 17483336
8. Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior. M Degen F Brellier R Kain C Ruiz L Terracciano G Orend R Chiquet-Ehrismann, Cancer Res 2007 67 19 9169 9179 10.1158/0008-5472.CAN-07-0666 17909022
9. Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? P Micke A Ostman, Lung Cancer 2004 45 Suppl 2 163 175 10.1016/j.lungcan.2004.07.977 15552797
10. Molecular aspects of stromal-parenchymal interactions in malignant neoplasms. A Zalatnai, Curr Mol Med 2006 6 6 685 693 10.2174/156652406778195053 17022738
11. 14-3-3 zeta protein secreted by tumor associated monocytes/macrophages from ascites of epithelial ovarian cancer patients. R Kobayashi M Deavers R Patenia T Rice-Stitt J Halbe S Gallardo RS Freedman, Cancer Immunol Immunother 2009 58 2 247 258 10.1007/s00262-008-0549-7 18618111
12. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. K Pietras J Pahler G Bergers D Hanahan, PLoS Med 2008 5 1 19 10.1371/journal.pmed.0050019 18232728
13. Friends or foes - bipolar effects of the tumour stroma in cancer. MM Mueller NE Fusenig, Nat Rev Cancer 2004 4 11 839 849 10.1038/nrc1477 15516957
14. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion. C Quemener EE Gabison B Naimi G Lescaille F Bougatef MP Podgorniak G Labarchede C Lebbe F Calvo S Menashi,, et al. Cancer Res 2007 67 1 9 15 10.1158/0008-5472. CAN-06-2448 17210677
15. The tumour microenvironment as a target for chemoprevention. A Albini MB Sporn, Nat Rev Cancer 2007 7 2 139 147 10.1038/nrc2067 17218951
16. Inflammation and cancer: role of nuclear factor-kappaB activation. S Maeda M Omata, Cancer Sci 2008 99 5 836 842 10.1111/j.1349-7006.2008.00763.x 18294278
17. Infections as a major preventable cause of human cancer. H Kuper HO Adami D Trichopoulos, J Intern Med 2000 248 3 171 183 10.1046/j.1365-2796.2000.00742. x 10971784
18. In vitro and in vivo studies on CCR10 regulation by Annexin A1. FC Rodrigues-Lisoni DK Mehet P Peitl Jr CD John WA da Silva Junior E Tajara JC Buckingham E Solito, FEBS Lett 2006 580 5 1431 1438 10.1016/j.febslet.2006.01. 072 16460738
19. Annexin 1: differential expression in tumor and mast cells in human larynx cancer. R Silistino-Souza FC Rodrigues-Lisoni PM Cury JV Maniglia LS Raposo EH Tajara HC Christian SM Oliani, Int J Cancer 2007 120 12 2582 2589 10.1002/ijc.22639 17340616
20. Annexin A1 subcellular expression in laryngeal squamous cell carcinoma. VA Alves S Nonogaki PM Cury V Wunsch-Filho MB de Carvalho P Michaluart-Junior RA Moyses OA Curioni DL Figueiredo C Scapulatempo-Neto,, et al. Histopathology 2008 53 6 715 727 10.1111/j.1365-2559.2008.03186.x 19076685
21. Pathways connecting inflammation and cancer. P Allavena C Garlanda MG Borrello A Sica A Mantovani, Curr Opin Genet Dev 2008 18 1 3 10 10.1016/j.gde.2008.01.003 18325755
22. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. AF Olumi GD Grossfeld SW Hayward PR Carroll TD Tlsty GR Cunha, Cancer Res 1999 59 19 5002 5011 10519415
23. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. A Orimo RA Weinberg, Cell Cycle 2006 5 15 1597 1601 16880743
24. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. B Elenbaas RA Weinberg, Exp Cell Res 2001 264 1 169 184 10.1006/excr.2000.5133 11237532
25. Breast carcinoma-associated fibroblasts and their counterparts display neoplastic-specific changes. NM Hawsawi H Ghebeh SF Hendrayani A Tulbah M Al-Eid T Al-Tweigeri D Ajarim A Alaiya S Dermime A Aboussekhra, Cancer Res 2008 68 8 2717 2725 10.1158/0008-5472.CAN-08-0192 18413739
26. Diversity, topographic differentiation, and positional memory in human fibroblasts. HY Chang JT Chi S Dudoit C Bondre M van de Rijn D Botstein PO Brown, Proc Natl Acad Sci USA 2002 99 20 12877 12882 10.1073/pnas.162488599 12297622
27. Fibroblasts in cancer. R Kalluri M Zeisberg, Nat Rev Cancer 2006 6 5 392 401 10.1038/nrc1877 16572188
28. The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. B Eyden, J Cell Mol Med 2008 12 1 22 37 10.1111/j.1582-4934.2007.00213.x 18182061
29. Tumor induction of VEGF promoter activity in stromal cells. D Fukumura R Xavier T Sugiura Y Chen EC Park N Lu M Selig G Nielsen T Taksir RK Jain,, et al. Cell 1998 94 6 715 725 10.1016/S0092-8674(00)81731-6 9753319
30. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. MD Sternlicht A Lochter CJ Sympson B Huey JP Rougier JW Gray D Pinkel MJ Bissell Z Werb, Cell 1999 98 2 137 146 10.1016/S0092-8674(00)81009-0 10428026
31. Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment. L Mueller FA Goumas M Affeldt S Sandtner UM Gehling S Brilloff J Walter N Karnatz K Lamszus X Rogiers,, et al. Am J Pathol 2007 171 5 1608 1618 10.2353/ajpath.2007.060661 17916596
32. Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts. EL Bair CP Massey NL Tran AH Borchers RL Heimark AE Cress GT Bowden, Exp Cell Res 2001 270 2 259 267 10.1006/excr.2001.5347 11640889
33. NF-kappaB involvement in tumor-stroma interaction of squamous cell carcinoma. T Ikebe H Nakayama M Shinohara K Shirasuna, Oral Oncol 2004 40 10 1048 1056 10.1016/j.oraloncology.2004.05.007 15509497
34. Collagen-based co-culture for invasive study on cancer cells-fibroblasts interaction. ZM Che TH Jung JH Choi J Yoon do HJ Jeong EJ Lee J Kim, Biochem Biophys Res Commun 2006 346 1 268 275 10.1016/j.bbrc.2006.05.111 16756953
35. Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo. W Zhang LM Matrisian K Holmbeck CC Vick EL Rosenthal, BMC Cancer 2006 6 52 10.1186/1471-2407-6-52 16515711
36. Targeting the tumor microenvironment. PA Kenny GY Lee MJ Bissell, Front Biosci 2007 12 3468 3474 10.2741/2327 17485314
37. Biomechanics and biophysics of cancer cells. S Suresh, Acta Biomater 2007 3 4 413 438 10.1016/j.actbio.2007.04.002 17540628 (Pubitemid 46865787)
38. Collagen alpha1(XI) in normal and malignant breast tissue. KC Halsted KB Bowen L Bond SE Luman CL Jorcyk WE Fyffe JD Kronz JT Oxford, Mod Pathol 2008 21 10 1246 1254 10.1038/modpathol.2008.129 18660795
39. OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumor. MJ Gough CE Ruby WL Redmond B Dhungel A Brown AD Weinberg, Cancer Res 2008 68 13 5206 5215 10.1158/0008-5472.CAN-07-6484 18593921
40. Drug insight: VEGF as a therapeutic target for breast cancer. BP Schneider GW Sledge Jr, Nat Clin Pract Oncol 2007 4 3 181 189 10.1038/ncponc0740 17327858
41. Targeted therapy in advanced non-small-cell lung cancer. S Gettinger, Semin Respir Crit Care Med 2008 29 3 291 301 10.1055/s-2008-1076749 18506667
42. Cytoskeletal rearrangements in synovial fibroblasts as a novel pathophysiological determinant of modeled rheumatoid arthritis. V Aidinis P Carninci M Armaka W Witke V Harokopos N Pavelka D Koczan C Argyropoulos MM Thwin S Moller,, et al. PLoS Genet 2005 1 4 48 10.1371/journal.pgen.0010048 16254600
43. Stable chromosome changes in human malignant melanoma. TR Chen MW Shaw, Cancer Res 1973 33 9 2042 2047 4725368
44. Epidermal growth factor receptors on cultured neoplastic human thyroid cells and effects of epidermal growth factor and thyroid-stimulating hormone on their growth. M Miyamoto H Sugawa T Mori K Hase K Kuma H Imura, Cancer Res 1988 48 13 3652 3656 3259906
45. A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. E Solito A Kamal F Russo-Marie JC Buckingham S Marullo M Perretti, FASEB J 2003 17 11 1544 1546 12824302
46. RaSH, a rapid subtraction hybridization approach for identifying and cloning differentially expressed genes. H Jiang DC Kang D Alexandre PB Fisher, Proc Natl Acad Sci USA 2000 97 23 12684 12689 10.1073/pnas.220431297 11058161
47. J Sambrook DW Russel, Molecular Cloning: a laboratory manual Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press 3 2001
48. BLAST. http://www.ncbi.nlm.nih.gov/BLAST/
49. GeneOntology. http://www.geneontology.org
50. A new mathematical model for relative quantification in real-time RT-PCR. MW Pfaffl, Nucleic Acids Res 2001 29 9 45 10.1093/nar/29.9.e45 11328886
51. Solubilization of proteins from human lymph node tissue and two-dimensional gel storage. AB de Marqui A Vidotto GM Polachini M Bellato Cde H Cabral AM Leopoldino JF de Gois Filho EE Fukuyama FA Settanni PM Cury,, et al. J Biochem Mol Biol 2006 39 2 216 222 16584638
52. MASCOT. http://www.matrixscience.com/cgi/search-form.pl?FORMVER= 2&SEARCH=MIS
53. UniProtKB/Swiss-Prot. http://ca.expasy.org/sprot/
54. Pathophysiologic significance of host reactions in human cancer tissue: desmoplasia and tumor immunity. H Ohtani, Tohoku J Exp Med 1999 187 3 193 202 10.1620/tjem.187.193 10458476
55. Role of tissue stroma in cancer cell invasion. O De Wever M Mareel, J Pathol 2003 200 4 429 447 10.1002/path.1398 12845611
56. Desmoplasia measured by computer assisted image analysis: an independent prognostic marker in colorectal carcinoma. B Sis S Sarioglu S Sokmen M Sakar A Kupelioglu M Fuzun, J Clin Pathol 2005 58 1 32 38 10.1136/jcp.2004.018705 15623479
57. Primary head and neck cancer. Histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement. KD Olsen M Caruso RL Foote RJ Stanley JE Lewis SJ Buskirk DA Frassica LW DeSanto WM O'Fallon VR Hoverman, Arch Otolaryngol Head Neck Surg 1994 120 12 1370 1374 7980903
58. Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells. DR Hurst Y Xie KS Vaidya A Mehta BP Moore MA Accavitti-Loper RS Samant R Saxena AC Silveira DR Welch, J Biol Chem 2008 283 12 7438 7444 10.1074/jbc.M709446200 18211900
59. Activated microglia modulate astroglial enzymes involved in oxidative and inflammatory stress and increase the resistance of astrocytes to oxidative stress in Vitro. C Rohl E Armbrust K Kolbe R Lucius E Maser S Venz M Gulden, Glia 2008 56 10 1114 1126 10.1002/glia.20683 18442093
60. Identification of chromatin remodeling genes Arid4a and Arid4b as leukemia suppressor genes. MY Wu KW Eldin AL Beaudet, J Natl Cancer Inst 2008 100 17 1247 1259 10.1093/jnci/djn253 18728284
61. Foxp3 in control of the regulatory T cell lineage. Y Zheng AY Rudensky, Nat Immunol 2007 8 5 457 462 10.1038/ni1455 17440451
62. Gene expression changes associated with altered growth and differentiation in benzo[a]pyrene or arsenic exposed normal human epidermal keratinocytes. DS Perez RJ Handa RS Yang JA Campain, J Appl Toxicol 2008 28 4 491 508 10.1002/jat.1301 17879257
63. Arsenic and benzo[a]pyrene differentially alter the capacity for differentiation and growth properties of primary human epidermal keratinocytes. DS Perez L Armstrong-Lea MH Fox RS Yang JA Campain, Toxicol Sci 2003 76 2 280 290 10.1093/toxsci/kfg232 12970582
64. Arsenite suppresses Notch1 signaling in human keratinocytes. TV Reznikova MA Phillips RH Rice, J Invest Dermatol 2009 129 1 155 161 10.1038/jid.2008.207 18633435
65. Arsenic trioxide, arsenic pentoxide, and arsenic iodide inhibit human keratinocyte proliferation through the induction of apoptosis. WP Tse CH Cheng CT Che ZX Lin, J Pharmacol Exp Ther 2008 326 2 388 394 10.1124/jpet.107.134080 18451318
66. The ins and outs of calreticulin: from the ER lumen to the extracellular space. S Johnson M Michalak M Opas P Eggleton, Trends Cell Biol 2001 11 3 122 129 10.1016/S0962-8924(01)01926-2 11306273
67. Calreticulin exposure dictates the immunogenicity of cancer cell death. M Obeid A Tesniere F Ghiringhelli GM Fimia L Apetoh JL Perfettini M Castedo G Mignot T Panaretakis N Casares,, et al. Nat Med 2007 13 1 54 61 10.1038/nm1523 17187072 (Pubitemid 46067386)
68. Recognition ligands on apoptotic cells: a perspective. SJ Gardai DL Bratton CA Ogden PM Henson, J Leukoc Biol 2006 79 5 896 903 10.1189/jlb.1005550 16641135
69. Calreticulin enhances porcine wound repair by diverse biological effects. LB Nanney CD Woodrell MR Greives NL Cardwell AC Pollins TA Bancroft A Chesser M Michalak M Rahman JW Siebert,, et al. Am J Pathol 2008 173 3 610 630 10.2353/ajpath.2008.071027 18753412
70. Differential calreticulin expression affects focal contacts via the calmodulin/CaMK II pathway. E Szabo S Papp M Opas, J Cell Physiol 2007 213 1 269 277 10.1002/jcp.21122 17516550
71. Altered expression of calreticulin during the development of fibrosis. KP Kypreou P Kavvadas P Karamessinis M Peroulis A Alberti P Sideras S Psarras Y Capetanaki PK Politis AS Charonis, Proteomics 2008 8 12 2407 2419 10.1002/pmic.200700831 18563736
72. RACK1 targets the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway to link integrin engagement with focal adhesion disassembly and cell motility. T Vomastek MP Iwanicki HJ Schaeffer A Tarcsafalvi JT Parsons MJ Weber, Mol Cell Biol 2007 27 23 8296 8305 10.1128/MCB.00598-07 17908799
73. The RACK1 scaffold protein: a dynamic cog in cell response mechanisms. A McCahill J Warwicker GB Bolger MD Houslay SJ Yarwood, Mol Pharmacol 2002 62 6 1261 1273 10.1124/mol.62.6.1261 12435793
74. RACK1 regulates Src activity and modulates paxillin dynamics during cell migration. AT Doan A Huttenlocher, Exp Cell Res 2007 313 12 2667 2679 10.1016/j.yexcr.2007.05.013 17574549
75. RACK1 inhibits colonic cell growth by regulating Src activity at cell cycle checkpoints. V Mamidipudi NK Dhillon T Parman LD Miller KC Lee CA Cartwright, Oncogene 2007 26 20 2914 2924 10.1038/sj.onc.1210091 17072338
76. Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain. I Joung JL Strominger J Shin, Proc Natl Acad Sci USA 1996 93 12 5991 5995 10.1073/pnas.93.12.5991 8650207
77. The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. A Duran JF Linares AS Galvez K Wikenheiser JM Flores MT Diaz-Meco J Moscat, Cancer Cell 2008 13 4 343 354 10.1016/j.ccr.2008.02.001 18394557
78. The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation. L Sanz P Sanchez MJ Lallena MT Diaz-Meco J Moscat, EMBO J 1999 18 11 3044 3053 10.1093/emboj/18.11.3044 10356400
79. The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway. L Sanz MT Diaz-Meco H Nakano J Moscat, EMBO J 2000 19 7 1576 1586 10.1093/emboj/19.7.1576 10747026
80. The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kappaB activation by nerve growth factor. MW Wooten ML Seibenhener V Mamidipudi MT Diaz-Meco PA Barker J Moscat, J Biol Chem 2001 276 11 7709 7712 10.1074/jbc.C000869200 11244088
81. Identification of interleukin 1 receptor-associated kinase as a conserved component in the p75-neurotrophin receptor activation of nuclear factor-kappa B. V Mamidipudi X Li MW Wooten, J Biol Chem 2002 277 31 28010 28018 10.1074/jbc.M109730200 12034707
82. p62 forms a ternary complex with PKCzeta and PAR-4 and antagonizes PAR-4-induced PKCzeta inhibition. S Chang JH Kim J Shin, FEBS Lett 2002 510 1-2 57 61 10.1016/S0014-5793(01)03224-0 11755531
83. Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituent. C Stumptner H Heid A Fuchsbichler H Hauser HJ Mischinger K Zatloukal H Denk, Am J Pathol 1999 154 6 1701 1710 10362795
84. p62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells. HG Thompson JW Harris BJ Wold F Lin JP Brody, Oncogene 2003 22 15 2322 2333 10.1038/sj.onc.1206325 12700667
85. Cytosolic overexpression of p62 sequestosome 1 in neoplastic prostate tissue. H Kitamura T Torigoe H Asanuma SI Hisasue K Suzuki T Tsukamoto M Satoh N Sato, Histopathology 2006 48 2 157 161 10.1111/j.1365-2559.2005.02313.x 16405664
86. The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive disease. P Rolland Z Madjd L Durrant IO Ellis R Layfield I Spendlove, Endocr Relat Cancer 2007 14 1 73 80 10.1677/erc.1.01312 17395976
87. Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines. U Rolen V Kobzeva N Gasparjan H Ovaa G Winberg F Kisseljov MG Masucci, Mol Carcinog 2006 45 4 260 269 10.1002/mc.20177 16402389
88. Targeting the ubiquitin-proteasome pathway in breast cancer therapy. EC Dees RZ Orlowski, Future Oncol 2006 2 1 121 135 10.2217/14796694.2.1.121 16556079
89. Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells. H Ovaa BM Kessler U Rolen PJ Galardy HL Ploegh MG Masucci, Proc Natl Acad Sci USA 2004 101 8 2253 2258 10.1073/pnas.0308411100 14982996
90. Over-expression of genes and proteins of ubiquitin specific peptidases (USPs) and proteasome subunits (PSs) in breast cancer tissue observed by the methods of RFDD-PCR and proteomics. S Deng H Zhou R Xiong Y Lu D Yan T Xing L Dong E Tang H Yang, Breast Cancer Res Treat 2007 104 1 21 30 10.1007/s10549-006-9393-7 17004105
91. RING domains: master builders of molecular scaffolds? KL Borden, J Mol Biol 2000 295 5 1103 1112 10.1006/jmbi.1999.3429 10653689
92. RING for destruction? PS Freemont, Curr Biol 2000 10 2 84 87 10.1016/S0960-9822(00)00287-6 10662664
93. Control of c-myc regulation in normal and neoplastic cells. CA Spencer M Groudine, Adv Cancer Res 1991 56 1 48 full-text 2028839
94. Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. A Subramanian DM Miller, J Biol Chem 2000 275 8 5958 5965 10.1074/jbc.275.8.5958 10681589
95. c-Myc: linking transformation and genomic instability. EV Prochownik, Curr Mol Med 2008 8 6 446 458 10.2174/156652408785747988 18781952
96. Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathways. C Grant U Oh K Fugo N Takenouchi C Griffith K Yao TE Newhook L Ratner S Jacobson, PLoS Pathog 2006 2 4 33 10.1371/journal.ppat.0020033 16652169
97. RACK-1 expression and cytokine production in leukocytes obtained from AD patients. M Racchi E Sinforiani S Govoni M Marinovich CL Galli E Corsini, Aging Clin Exp Res 2006 18 2 153 157 16702786
98. Signal integration and diversification through the p62 scaffold protein. J Moscat MT Diaz-Meco MW Wooten, Trends Biochem Sci 2007 32 2 95 100 10.1016/j.tibs.2006.12.002 17174552
99. Gpnmb is induced in macrophages by IFN-gamma and lipopolysaccharide and acts as a feedback regulator of proinflammatory responses. VM Ripoll KM Irvine T Ravasi MJ Sweet DA Hume, J Immunol 2007 178 10 6557 6566 17475886